Phase 1 Study of Anti-glycation Agent GLY-230 in Healthy Subjects
- First Posted Date
- 2007-10-16
- Last Posted Date
- 2016-02-10
- Lead Sponsor
- Glycadia
- Target Recruit Count
- 54
- Registration Number
- NCT00544921
- Locations
- 🇺🇸
Univ FL, Gainesville, Florida, United States
Multiple Dose Trial of Anti-glycation Agent GLY-230 in Healthy and Diabetic Subjects
- First Posted Date
- 2007-10-16
- Last Posted Date
- 2016-02-10
- Lead Sponsor
- Glycadia
- Target Recruit Count
- 42
- Registration Number
- NCT00544934
© Copyright 2025. All Rights Reserved by MedPath